Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018

• Published in: Tropical Medicine and Health
• Main Authors: Aye Mya Chan Thar, Khin Thet Wai, Anthony D. Harries, Kyaw Lwin Show, Lei Lei Mon, Htar Htar Lin
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMC 2020
• Subjects: Myanmar; Measles cases; Measles deaths; Measles vaccination coverage; Measles containing vaccine 1—MCV1; Measles containing vaccine 2—MCV2; Arctic medicine. Tropical medicine; RC955-962; Arctic
• Online Access: https://doi.org/10.1186/s41182-020-0191-4; https://doaj.org/article/9f3b09e9fbc747a78a4944c54203c9de

Abstract Background There is a global resurgence of measles, consequent upon worldwide stagnating measles vaccination coverage. The study aim was to document trends and characteristics of reported cases of measles, measles-related deaths, and measles vaccination coverage (MCV1—first dose of measles-containing vaccine and MCV2—second dose of measles-containing vaccine) at national and sub-national level in Myanmar over a five year period between 2014 and 2018. Methods This was a descriptive study using routine data collected and submitted to the Expanded Programme on Immunization. Results Between 2014 and 2018, there were 2673 measles cases of which 2272 (85%) occurred in 2017 and 2018. Five adjacent regions in lower Myanmar were the most affected: in 2017 and 2018, these regions reported 1647 (73%) of the 2272 measles cases in the country. Overall, 73% of measles cases were laboratory confirmed, 21% were epidemiologically linked, and 6% were clinically compatible (clinical diagnosis only), with more laboratory confirmed cases in recent years. Annual measles-related deaths were either zero or one except in 2016 when there were 21 deaths, all occurring in one remote village. In the recent years, the most commonly affected age groups were 0–8 months, 9 months to 4 years, and ≥ 15 years. Among 1907 measles cases with known vaccination status, only 22% had been vaccinated and 70% of those had only received one dose of vaccine. Annual MCV1 coverage nationally varied from 83 to 93% while annual MCV2 coverage nationally varied from 78 to 87%, with no clear trends over the years. Between 2014 and 2018, a high proportion of the 330 townships had MCV coverage < 95%. Over 80% of measles cases were reported from townships that had MCV coverage < 95%. Conclusion There have been a large number of measles cases in recent years associated with sub-optimal measles vaccine coverage. Myanmar has already conducted supplemental immunization activities in October and November, 2019. Myanmar also needs to improve routine ...